Build status - In Progress

Assessing Drug Epetraborole in Patients with Mycobacterium avium Complex Lung Disease (MACrO2)

Recruiting
18 years - 99 years
All
5 participants needed
1 Location

Brief description of study

The purpose of this study is to learn about the effects of a study drug, Epetraborole, to assess the efficacy for treating refractory MAC. It will enroll patients over 18 years of age and will include the following: physical exams, CTs, medical history, ECGs, lung function tests, vital signs, safety labs, PK labs, and questionnaires. Participants will be paid $50 for each study visit.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research, Mycobacterium avium Complex Lung Disease (MACrO2)
  • Age: 18 years - 99 years
  • Gender: All
Updated on 04 Aug 2024. Study ID: 851421

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center